Kim Lorence H.insider trades
In SEC Form 4 filings, Kim Lorence H. is listed as Director of Revolution Medicines, Inc. (RVMD). In the last 90 days, Kim Lorence H. sold $14.97M of Revolution Medicines, Inc. (RVMD) on the open market and bought none. All 14 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RVMDRevolution Medicines, Inc. | Director | 14 | Sep 10 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | Sep 8 | Sep 10 | S | 706 | $206.60 | Sale −$145,863 | 16,384 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 8 | Sep 10 | S | 999 | $207.33 | Sale −$207,125 | 15,385 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 8 | Sep 10 | S | 3,587 | $208.55 | Sale −$748,081 | 11,798 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 8 | Sep 10 | S | 2,853 | $209.56 | Sale −$597,875 | 8,945 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 8 | Sep 10 | S | 4,730 | $210.50 | Sale −$995,678 | 4,215 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 8 | Sep 10 | S | 3,844 | $211.36 | Sale −$812,463 | 371 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Sep 8 | Sep 10 | S | 371 | $212.27 | Sale −$78,752 | not reported | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 31 | Sep 2 | S | 300 | $200.56 | Sale −$60,168 | 72,790 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 31 | Sep 2 | S | 6,597 | $201.47 | Sale −$1,329,117 | 66,193 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 31 | Sep 2 | S | 12,919 | $202.48 | Sale −$2,615,864 | 53,274 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 31 | Sep 2 | S | 26,160 | $203.55 | Sale −$5,324,824 | 27,114 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 31 | Sep 2 | S | 7,271 | $204.35 | Sale −$1,485,830 | 19,843 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 31 | Sep 2 | S | 2,128 | $205.19 | Sale −$436,640 | 17,715 | Yes | Form 4 |
| RVMDRevolution Medicines, Inc. | Aug 31 | Sep 2 | S | 625 | $206.15 | Sale −$128,846 | 17,090 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.